• 1.四川大學(xué)華西醫(yī)院腎臟內(nèi)科(成都 610041)2.四川大學(xué)高分子科學(xué)與工程學(xué)院(成都610065);

目的  比較尿毒癥患者使用國(guó)產(chǎn)高通量聚醚砜透析器和進(jìn)口聚砜膜血液透析器在血液透析中的有效性和安全性。
方法  選擇符合標(biāo)準(zhǔn)的血液透析患者40例,采用隨機(jī)數(shù)字表法生成隨機(jī)順序,將患者隨機(jī)分為聚醚砜組和聚砜組各20例,分別使用國(guó)產(chǎn)高通量聚醚砜血液透析器和進(jìn)口聚砜膜血液透析器進(jìn)行高通量透析4 h。以肌酐、尿素氮和血β2微球蛋白下降和透析前后外周血Hb、Alb等指標(biāo)的變化進(jìn)行療效和安全性評(píng)估。
結(jié)果  本研究納入的40例全部完成試驗(yàn),無一例失訪。結(jié)果顯示,兩組受試者在使用兩種透析器透析后均可使血肌酐、尿素氮和血β2微球蛋白下降,且兩組的下降幅度相當(dāng)(P均 gt;0.05)。反應(yīng)透析充分性的指標(biāo)KT/V值的變化也顯示兩組透析的充分程度相當(dāng)(P gt;0.05);而透析安全性的指標(biāo)如血Hb、Alb和血壓,在兩組透析前后差異無統(tǒng)計(jì)學(xué)意義。
結(jié)論  高通量聚醚砜透析器對(duì)尿毒癥患者進(jìn)行高通量透析,其療效和安全性與高通量聚砜透析器相當(dāng)。

引用本文: 蘇白海,李 孜,陶 冶,沙朝暉,付 平,趙長(zhǎng)生. 國(guó)產(chǎn)高通量聚醚砜血液透析器對(duì)尿毒癥患者進(jìn)行血液透析的隨機(jī)雙盲對(duì)照試驗(yàn). 中國(guó)循證醫(yī)學(xué)雜志, 2006, 06(7): 474-478. doi: 復(fù)制

1. 王質(zhì)剛 主編. 血液凈化學(xué). 第2版. 北京: 北京科學(xué)技術(shù)出版社; 2005.
2. 郝繼英, 王質(zhì)剛. 高通量透析的臨床研究. 腎臟病與透析腎移植雜志, 1998; 7(2): 130~133, 204.
3. Lipps B, Stewart R, Perkins H, et al. The hollow fiber artificial kidney. Trans Am Soc Artif Intern Org, 1969; 13: 200-207.
4. Morti S, Shao JH, Zydney AL. Importance of asymmetric structure in determining mass transport characteristics of hollow fiber hemodialyzers. J Membrane Sci, 2003; 224: 39-49.
5. Baeyer HV, Lajous-Petter A, Debrandt W, et al. Surface reactions on blood contact during hemodialysis and haemofiltration with various membrane types. J Membrane Sci, 1988; 36: 215-222.
6. Zhao CS, Liu T, Lu ZP, et al. An evaluation of a polyethersulfone hollow fiber plasma separator by animal experiment. Artif Organs, 2001; 25(1): 60-63.
7. In: Wang ZG, ed. Blood Purification. 2nd Edition. Beijing: Beijing science technique publishing company; 2005.
8. Hao JY, Wang ZG. Clinical Evaluation of Highly Permeable Dialysis. J Nephrol Dialy Transplant, 1998; 7(2): 130-133, 204.
  1. 1. 王質(zhì)剛 主編. 血液凈化學(xué). 第2版. 北京: 北京科學(xué)技術(shù)出版社; 2005.
  2. 2. 郝繼英, 王質(zhì)剛. 高通量透析的臨床研究. 腎臟病與透析腎移植雜志, 1998; 7(2): 130~133, 204.
  3. 3. Lipps B, Stewart R, Perkins H, et al. The hollow fiber artificial kidney. Trans Am Soc Artif Intern Org, 1969; 13: 200-207.
  4. 4. Morti S, Shao JH, Zydney AL. Importance of asymmetric structure in determining mass transport characteristics of hollow fiber hemodialyzers. J Membrane Sci, 2003; 224: 39-49.
  5. 5. Baeyer HV, Lajous-Petter A, Debrandt W, et al. Surface reactions on blood contact during hemodialysis and haemofiltration with various membrane types. J Membrane Sci, 1988; 36: 215-222.
  6. 6. Zhao CS, Liu T, Lu ZP, et al. An evaluation of a polyethersulfone hollow fiber plasma separator by animal experiment. Artif Organs, 2001; 25(1): 60-63.
  7. 7. In: Wang ZG, ed. Blood Purification. 2nd Edition. Beijing: Beijing science technique publishing company; 2005.
  8. 8. Hao JY, Wang ZG. Clinical Evaluation of Highly Permeable Dialysis. J Nephrol Dialy Transplant, 1998; 7(2): 130-133, 204.